Cargando…

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

PURPOSE: There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Riera, Rachel, Bagattini, Ângela Maria, Pacheco, Rafael Leite, Pachito, Daniela Vianna, Roitberg, Felipe, Ilbawi, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081532/
https://www.ncbi.nlm.nih.gov/pubmed/33617304
http://dx.doi.org/10.1200/GO.20.00639
_version_ 1783685661364060160
author Riera, Rachel
Bagattini, Ângela Maria
Pacheco, Rafael Leite
Pachito, Daniela Vianna
Roitberg, Felipe
Ilbawi, Andre
author_facet Riera, Rachel
Bagattini, Ângela Maria
Pacheco, Rafael Leite
Pachito, Daniela Vianna
Roitberg, Felipe
Ilbawi, Andre
author_sort Riera, Rachel
collection PubMed
description PURPOSE: There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS: This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS: Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION: The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.
format Online
Article
Text
id pubmed-8081532
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-80815322021-04-29 Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review Riera, Rachel Bagattini, Ângela Maria Pacheco, Rafael Leite Pachito, Daniela Vianna Roitberg, Felipe Ilbawi, Andre JCO Glob Oncol REVIEW ARTICLES PURPOSE: There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS: This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS: Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION: The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review. American Society of Clinical Oncology 2021-02-22 /pmc/articles/PMC8081532/ /pubmed/33617304 http://dx.doi.org/10.1200/GO.20.00639 Text en © 2021 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle REVIEW ARTICLES
Riera, Rachel
Bagattini, Ângela Maria
Pacheco, Rafael Leite
Pachito, Daniela Vianna
Roitberg, Felipe
Ilbawi, Andre
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
title Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
title_full Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
title_fullStr Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
title_full_unstemmed Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
title_short Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
title_sort delays and disruptions in cancer health care due to covid-19 pandemic: systematic review
topic REVIEW ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081532/
https://www.ncbi.nlm.nih.gov/pubmed/33617304
http://dx.doi.org/10.1200/GO.20.00639
work_keys_str_mv AT rierarachel delaysanddisruptionsincancerhealthcareduetocovid19pandemicsystematicreview
AT bagattiniangelamaria delaysanddisruptionsincancerhealthcareduetocovid19pandemicsystematicreview
AT pachecorafaelleite delaysanddisruptionsincancerhealthcareduetocovid19pandemicsystematicreview
AT pachitodanielavianna delaysanddisruptionsincancerhealthcareduetocovid19pandemicsystematicreview
AT roitbergfelipe delaysanddisruptionsincancerhealthcareduetocovid19pandemicsystematicreview
AT ilbawiandre delaysanddisruptionsincancerhealthcareduetocovid19pandemicsystematicreview